These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8960771)

  • 1. Posttranslational modifications of brain and erythrocyte band 3 during aging and disease.
    Kay MM; Rapcsak SZ; Bosman GJ; Goodman JR
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):919-44. PubMed ID: 8960771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Band 3 and its peptides during aging, radiation exposure, and Alzheimer's disease: alterations and self-recognition.
    Kay MM; Lake D; Cover C
    Adv Exp Med Biol; 1995; 383():167-93. PubMed ID: 8644501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigen.
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):131-53. PubMed ID: 8513271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and erythrocyte anion transporter protein, band 3, as a marker for Alzheimer's disease: structural changes detected by electron microscopy, phosphorylation, and antibodies.
    Kay MM; Goodman J
    Gerontology; 1997; 43(1-2):44-66. PubMed ID: 8996829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of senescent cell antigen on brain anion exchanger protein (AE) isoforms using HPLC and fast atom bombardment ionization mass spectrometry (FAB-MS).
    Kay MM; Goodman J
    J Mol Recognit; 2004; 17(1):33-40. PubMed ID: 14872535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational changes in band 3 in adult and aging brain following treatment with ergoloid mesylates, comparison to changes observed in Alzheimer's disease.
    Cover CC; Poulin JE; Gustafson MR; Wyant T; Gamble DN; Kay MM
    Life Sci; 1996; 58(8):655-64. PubMed ID: 8594315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane protein band 3 alteration associated with neurologic disease and tissue-reactive antibodies.
    Kay MM; Goodman J; Goodman S; Lawrence C
    Exp Clin Immunogenet; 1990; 7(3):181-99. PubMed ID: 2383405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation of cellular life span.
    Kay M
    Ann N Y Acad Sci; 2005 Dec; 1057():85-111. PubMed ID: 16399889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of human band-3 mutation associated with increased anion transport.
    Kay MM; Bosman G; Johnson RC; Poulin J; Lawrence C; Goodman J
    Exp Clin Immunogenet; 1994; 11(4):209-21. PubMed ID: 7857667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human erythroid band 3 "anion exchanger 1" is expressed in transformed lymphocytes.
    Kay MM; Vollard CH
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):945-52. PubMed ID: 8960772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational changes in band 3 in aging and Alzheimer's disease: do anion and glucose transport changes reflect or foreshadow the eventual metabolic abnormalities?
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 1998 Feb; 44(1):271-2. PubMed ID: 9551658
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies to band 3 during aging and disease and aging interventions.
    Kay MM; Wyant T; Goodman J
    Ann N Y Acad Sci; 1994 May; 719():419-47. PubMed ID: 7516632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte aging: a comparison of model systems for simulating cellular aging in vitro.
    Bosman GJ; Kay MM
    Blood Cells; 1988; 14(1):19-46. PubMed ID: 3179456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of band 3 transport protein by cellular aging and disease: erythrocyte band 3 and glucose transporter share a functional relationship.
    Bosman GJ; Kay MM
    Biochem Cell Biol; 1990 Dec; 68(12):1419-27. PubMed ID: 2085437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sorting of tyrosine kinases and phosphotyrosine phosphatases acting on band 3 during vesiculation of human erythrocytes.
    Minetti G; Ciana A; Balduini C
    Biochem J; 2004 Jan; 377(Pt 2):489-97. PubMed ID: 14527338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E prevents oxidative modification of brain and lymphocyte band 3 proteins during aging.
    Poulin JE; Cover C; Gustafson MR; Kay MB
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5600-3. PubMed ID: 8643622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte aging in sickle cell disease.
    Bosman GJ
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):81-6. PubMed ID: 15040431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of aging- and degeneration-related changes in anion exchange proteins for the maintenance of neuronal homeostasis.
    Bosman GJ; Engbersen A; Vollaard CH; Bartholomeus IG; Pistorius AM; Renkawek K; De Grip WJ
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):905-18. PubMed ID: 8960770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
    Salhany JM; Sloan RL; Cordes KS
    Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocytes anion transport and oxidative change in beta-thalassaemias.
    Maria C; Leonardo R; Pietro R; Mario V; Isabella V; Diana T
    Cell Biol Int; 2010 May; 34(6):655-62. PubMed ID: 20450494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.